ArticlePediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology2004
Childhood severe acute respiratory syndrome, coronavirus infections and asthma.
Article in Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.
- SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic Review.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020Pooled it
- COVID-19 Infection in Children and Infants: Current Status on Therapies and Vaccines.Children (Basel, Switzerland) · 2022Review
- School Asthma Care During COVID-19: What We Have Learned and What We Are Learning.The journal of allergy and clinical immunology. In practice · 2022Article
- The Impact of Coronavirus Disease 2019 on Pediatric Asthma in the United States.Pediatric clinics of North America · 2021Review
- Article
- Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort.Allergy · 2021Article
- School Attendance, Asthma Risk, and COVID-19 in Children.The journal of allergy and clinical immunology. In practice · 2021Article
- Article
- Implications of preexisting asthma on COVID-19 pathogenesis.American journal of physiology. Lung cellular and molecular physiology · 2021Review
- COVID-19 and bronchial asthma: current perspectives.Global health & medicine · 2021Review
- Zoonotic coronavirus epidemics: Severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease 2019.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2021Review
- Interrelations between COVID-19 and other disorders.Clinical immunology (Orlando, Fla.) · 2021Review
- Article
- Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness.The journal of allergy and clinical immunology. In practice · 2021Article
- Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon.The Journal of allergy and clinical immunology · 2021Article
- The Impact of the SARS-CoV-2 Pandemic on the Emergency Department and Management of the Pediatric Asthmatic Patient.Journal of asthma and allergy · 2021Article
- COVID-19-Related Pneumonia in an Adolescent Patient with Allergic Asthma.Case reports in medicine · 2021Article
- Inflammatory Mechanism and Clinical Implication of Asthma in COVID-19.Clinical medicine insights. Circulatory, respiratory and pulmonary medicine · 2021Review
- Virus-Induced Wheezing With COVID-19.Indian pediatrics · 2020Article
- Update on COVID-19: A teleconference with the Paediatric Virology Study Group (Review).Experimental and therapeutic medicine · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe acute respiratory syndrome (SARS) is a new infectious disease caused by a novel coronavirus. Children appear to be less susceptible to the SARS coronavirus, although the other non-SARS coronaviruses can cause respiratory infections in adults and in children of all ages. The exact reasons as to why SARS preferentially affects adults, and not children, are still unknown. Many hypotheses exist and need to be explored. During the outbreak of SARS, there did not appear to be an increase in asthma exacerbations in children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.